The core activity of Sanakin BioScience SA is the development and marketing of the Sanakin technology, which enables the production of 100% autologous serum (ACRS) from patients' blood. This serum is used to regulate inflammatory processes and stimulate tissue regeneration in a natural way. The company focuses on applying this technology in various medical specialties, including orthopedics, spinal surgery, sports medicine, aesthetics, dermatology, wound healing, dentistry, gynecology, and ophthalmology.